Gilbert Cisneros · AORT
Gilbert Cisneros's AORT trades
- Transactions
- 3
- Buys / sells
- 2 / 1
- Disclosed range
- $3K – $45K
- Last filed
- 2026-09-10
AORT transactions reported by Gilbert Cisneros
| Type | Owner | ||||
|---|---|---|---|---|---|
Artivion, Inc. Common Stock AORT | Purchase | Self | $1,001 - $15,000 | 2026-09-10 #20035390 | |
Artivion, Inc. Common Stock AORT | Purchase | Self | $1,001 - $15,000 | 2026-09-04 #20035190 | |
Artivion, Inc. Common Stock AORT | Sale | Self | $1,001 - $15,000 | 2025-11-18 #20033455 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
The tracker is free
A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.
More tickers reported by Gilbert Cisneros
Gilbert Cisneros and AORT — questions
Did Gilbert Cisneros buy or sell AORT?
House Clerk filings for 2025 and 2026 show 2 purchases and 1 sale of Artivion, Inc. Common Stock (AORT) reported by Gilbert Cisneros, between 2025-10-09 and 2026-08-20. Reported owner: Self.
How much AORT did Gilbert Cisneros trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K – $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last AORT filing by Gilbert Cisneros?
The most recent periodic transaction report containing a AORT row was filed on 2026-09-10. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Artivion, Inc. Common Stock. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Gilbert Cisneros AORT disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included